SavedAdd your journal

Journals / Eurasian Journal of Medical Investigation / 2019 / Cilt: 3 - Sayı: 1

How to Effect of Metformin Adding to Cyproterone Acetate+Ethinyl Estradiol Treatment on Antioxidant Status in Polycystıc Ovary Syndrome?

Burcu YAPAR TASKÖYLÜ
Melahat Semin FENKCİ
Özer ÖZTEKİN
Yaşar ENLİ
Senay TOPSAKAL
Guzin Fidan YAYLALI
Pages
14–18
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Oxidative stressparameters were decreased in both groups but with addition of metformin treatment there is no effect on oxidant andantioxidant status in polycystic ovary syndrome.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: Polycystic Ovary Syndrome (PCOS) is the most commonly seen endocrinopathy that affects the womenof reproductive age.
📊
Key Findings & Data:We aimed to determine relationship between insulin resistance and oxidant/antioxidant statusin women with PCOS and evaluate the effect of metformin combined with cyproterone acetate+ethinyl estradiol onoxidative stress in patients with PCOS.Methods: 30 women with PCOS and 20 healty controls enrolled in the study.
💡
Conclusion & Impact:Oxidative stressparameters were decreased in both groups but with addition of metformin treatment there is no effect on oxidant andantioxidant status in polycystic ovary syndrome.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objectives: Polycystic Ovary Syndrome (PCOS) is the most commonly seen endocrinopathy that affects the womenof reproductive age. We aimed to determine relationship between insulin resistance and oxidant/antioxidant statusin women with PCOS and evaluate the effect of metformin combined with cyproterone acetate+ethinyl estradiol onoxidative stress in patients with PCOS.Methods: 30 women with PCOS and 20 healty controls enrolled in the study. Women with PCOS divided into twogroups according to insulin resistance. Superoxide dismutase, Glutathione peroxidase, Glutathione, Malonyldialdehyde,Myeloperoxidase level results were compared both in PCOS and control groups.Results: Malonyldialdehyde was statistically significant in PCOS patients compared to the control group. MDA levelsincreased as the waist circumference increased. MDA and MPO enzymes were found to be significantly low after treatmentin both groups compared to the pretreatment levels.Conclusion: An increase in oxidant status was found in women with PCOS according to control groups. Oxidative stressparameters were decreased in both groups but with addition of metformin treatment there is no effect on oxidant andantioxidant status in polycystic ovary syndrome.

🔖

Cite This Article

TASKÖYLÜ, B. Y., FENKCİ, M. S., ÖZTEKİN, Ö., ENLİ, Y., TOPSAKAL, S., YAYLALI, G. F. (2022). How to Effect of Metformin Adding to Cyproterone Acetate+Ethinyl Estradiol Treatment on Antioxidant Status in Polycystıc Ovary Syndrome?. Eurasian Journal of Medical Investigation, Cilt: 3 - Sayı: 1, 14–18. https://ajindex.com/articles/508729

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004;81:19–25
  2. Okhawa H, Ohishi N. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979;95:351–8
  3. Winterbourn CC, Hawkings RE, Brian M, Carrel RW. The estimation of red cells superoxide dismutase activity. J Lab Clin Med 1975;85:337–42
  4. Moron MS, Depierre JW, Mannervik B. Level of glutathione, glutathione reductase and glutathione-S-transferase activity in rat lung and liver. Biochem Biophys Acta 1979;82:67–78
  5. Knight KR, Zhang B, Morrison WA, Stewart AG. Ischaemiareferfüsion injury in mouse skeletal muscle is reduced by Nnitro- L-arginine methyl ester and dexamethasone. Eur J of Pharmacol 1997;332:273–78
  6. Burghen GA, Givens JR, Kitabchi AE. Correlation of hyperandrogenism with hyperinsülinism in polycystic ovarian disease. J Clin Endocrinol Metab 1980;50:113–16
  7. Dunaif A, Xia J, Book CB, Schenker E, Tang Z. Excessive insülinreceptor serine phosphorylation in cultured fibroblasts and in skeletal muscle. A potential mechanism for insülin resistance in the polycystic ovary syndrome. J Clin Invest 1995;96:801– 10
  8. Tuma DJ. Role of Malondialdehit-Asetaldehit adducts in liver injury. Free Radical Biology & Medicine 2002;32:303–8
  9. Fenkci V, Fenkci S, Yilmazer M, Serteser M. Decreased total antioxidant status and increased oxidative stress in women with polycystic ovary syndrome may contribute to the risk of cardiovascular disease. Fertil Steril 2003;80:123–7
  10. Talbott E, Guzick D, Clerici A, Berga S, Detre K, Weimer K, et al. Coronary heart disease risk factors in women with polycystic ovary syndrome. Arter Throm Vas Biol 1995;15:821–6.